Fig. 2From: Short-term outcomes in patients with center-involving diabetic macular edema after a single dose of intravitreal bevacizumabColumn charts illustrating mean change in BCVA and OCT metrics from baseline in response subgroups. The responder subgroup included 22 eyes and the non-responder subgroup 30 eyes. A Best-corrected visual acuity. B Central subfield thickness. C Total macular volume. P-values were derived from paired Student’s t-tests and Wilcoxon signed rank tests. Significant at p < 0.05Back to article page